How to Choose a CJC-1295 DAC Supplier
Evaluating a CJC-1295 DAC supplier requires rigorous scrutiny of chemical purity, analytical transparency, and supply chain integrity. As a modified growth hormone-releasing hormone (GHRH) analog featuring Drug Affinity Complex technology, CJC-1295 DAC is investigated for its capacity to sustain growth hormone (GH) and downstream insulin-like growth factor 1 (IGF-1) secretion in tissue repair research. This guide establishes the technical, analytical, and operational standards necessary to procure high-purity research compounds for institutional laboratory applications.
Quick answer
Evaluating a CJC-1295 DAC supplier requires rigorous scrutiny of chemical purity, analytical transparency, and supply chain integrity. As a modified growth hormone-releasing hormone (GHRH) analog featuring Drug Affinity Complex technology, CJC-1295 DAC is investigated for its capacity to sustain growth hormone (GH) and downstream insulin-like growth factor 1 (IGF-1) secretion in tissue repair research. This guide establishes the technical, analytical, and operational standards necessary to procure high-purity research compounds for institutional laboratory applications.
Key takeaways
- [CJC-1295](/research-peptides/cjc-1295-no-dac) with Drug Affinity Complex (DAC) is a 30-amino acid synthetic peptide analog of endogenous growth hormone-releasing hormone (GHRH).
- When designing in vitro or animal models targeting the growth hormone axis, investigators often evaluate [CJC-1295](/research-peptides/cjc-1295-no-dac) DAC alongside shorter-acting analogs and complementary secretagogues.
- The primary factor in evaluating a [cjc-1295 dac supplier](/product/cjc-1295-dac) is the geographic and facility origin of the chemical synthesis.
- A reliable supplier must provide a lot-specific [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) for every batch of [CJC-1295](/research-peptides/cjc-1295-no-dac) DAC.
Understanding CJC-1295 DAC: Chemical Architecture and Research Applications
CJC-1295 with Drug Affinity Complex (DAC) is a 30-amino acid synthetic peptide analog of endogenous growth hormone-releasing hormone (GHRH). The integration of the DAC moiety—specifically a maleimido-propionic acid linker attached to the lysine residue at position 30—allows the peptide to covalently bind to endogenous serum albumin upon administration in preclinical models. This bio-conjugation significantly extends the biological half-life of the compound from minutes to several days compared to unmodified GHRH peptides.
In laboratory settings, research models demonstrate that CJC-1295 DAC stimulates the anterior pituitary gland to release GH in a continuous, non-pulsatile manner, driving sustained elevation of downstream insulin-like growth factor 1 (IGF-1). Researchers utilize research-grade CJC-1295 DAC to investigate long-term somatotrophic axis activation, cellular proliferation, metabolic rate regulation, and extracellular matrix remodeling in tissue repair research. Because experimental results rely heavily on consistent receptor binding affinity and predictable pharmacokinetic profiles, procurement teams must ensure that every batch of this peptide meets strict structural and purity criteria.
Comparing CJC-1295 DAC to Related GHRH and Secretagogue Peptides
When designing in vitro or animal models targeting the growth hormone axis, investigators often evaluate CJC-1295 DAC alongside shorter-acting analogs and complementary secretagogues. Understanding the functional differences among these GHRH analogs is essential for selecting the correct compound for specific research endpoints.
Unlike CJC-1295 No DAC (also known as Mod GRF 1-29), which lacks the albumin-binding linker and produces rapid, transient GH spikes, CJC-1295 DAC delivers prolonged systemic exposure. Similarly, truncated GHRH fragments like sermorelin possess short elimination half-lives requiring frequent administration in preclinical study designs. When researchers seek synergistic receptor stimulation, GHRH analogs are frequently paired in experimental designs with ghrelin receptor agonists such as ipamorelin to evaluate co-activation of distinct pituitary signaling pathways. Sourcing from a comprehensive vendor guarantees that all comparative peptides are synthesized under identical quality control standards.
Criterion 1: USA Synthesis and Manufacturing Standards
The primary factor in evaluating a cjc-1295 dac supplier is the geographic and facility origin of the chemical synthesis. Peptides synthesized in domestic, GMP-compliant facilities adhere to standard operating procedures that mitigate batch-to-batch variability, cross-contamination, and synthetic side-product accumulation.
Overseas manufacturing operations often utilize truncated synthesis cycles or lower-grade protective groups to reduce costs, leading to deletion sequences and isomeric impurities that interfere with binding assays. Choosing USA-synthesized research peptides ensures strict compliance with high-performance liquid chromatography (HPLC) purification protocols and solid-phase peptide synthesis (SPPS) standards. PX1 Research synthesizes compounds domestically, providing institutional laboratories with reliable chemical uniformity across longitudinal studies.
Criterion 2: Analytical Verification via Lot-Specific HPLC and Mass Spectrometry
A reliable supplier must provide a lot-specific Certificate of Analysis (COA) for every batch of CJC-1295 DAC. Generic or outdated analytical reports do not confirm the purity or identity of the specific vial delivered to your laboratory. Investigators should verify that every COA includes data from an independent, ISO 17025-accredited third-party laboratory.
Verification requires two primary analytical techniques: High-Performance Liquid Chromatography (HPLC) to confirm chemical purity (which should exceed 98.0%), and Mass Spectrometry (MS) to verify molecular weight and chemical structure. For CJC-1295 DAC, liquid chromatography-mass spectrometry (LC-MS) confirms the precise addition of the Drug Affinity Complex linker. You can explore verified analytical reports across our product catalog in the PX1 research library.
Criterion 3: Endotoxin Testing for In Vitro and Animal Models
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are common contaminants in synthetic peptide manufacturing. In cell culture models and animal studies, even minute levels of endotoxin can trigger inflammatory cytokine cascades, confound physiological data, or cause acute cellular toxicity.
A qualified CJC-1295 DAC supplier must perform quantitative endotoxin testing, typically using Chromogenic Limulus Amebocyte Lysate (LAL) assays or recombinant Factor C (rFC) assays. Research-grade compounds should demonstrate endotoxin levels well below established preclinical safety thresholds (typically < 0.01 EU/μg). Confirming low endotoxin content protects the validity of tissue repair models and prevents unmapped immunogenic variables.
Criterion 4: Cold-Chain Logistics, Lyophilization, and Shipping Integrity
Peptides are sensitive biomolecules susceptible to hydrolytic degradation, oxidation, and aggregation if exposed to thermal stress or moisture during transit. Professional suppliers utilize advanced lyophilization (freeze-drying) protocols to produce highly stable, moisture-controlled cake formulations that resist physical degradation.
Furthermore, cold-chain handling and rapid order fulfillment are vital. PX1 Research operates strategic dispatch hubs in California and Arizona, facilitating same-day shipping for orders placed Monday through Friday prior to cutoff times. Lyophilized vials are packed in temperature-buffered, light-shielded packaging to preserve structural integrity from the synthesis lab to your facility.
Criterion 5: Vendor Reliability, Guarantees, and Institutional Accounts
Procurement officers and principal investigators require transparent vendor policies to safeguard research investments. A trustworthy supplier maintains a clear refund and replacement policy for any compound that fails to meet published HPLC/MS specifications or arrives damaged.
Additionally, institutional buyers managing high-volume screening protocols require tailored account management options. PX1 Research supports institutional procurement through flexible purchase orders, lot reservation programs, and dedicated support for bulk laboratory procurement. Working with an established vendor minimizes supply chain disruptions and ensures long-term experimental reproducibility.
Laboratory Protocols: Reconstitution, Handling, and Storage Guidelines
To preserve the bioactivity of CJC-1295 DAC after delivery, laboratory personnel must follow standard handling procedures. Lyophilized peptides should be stored in a dry, dark environment at -20°C prior to reconstitution. Upon arrival, vials should be allowed to acclimate to room temperature inside a desiccator before opening to prevent atmospheric moisture condensation.
Reconstitution for in vitro or analytical assays should be conducted under a laminar flow hood using sterile bacteriostatic water or laboratory-grade diluents. Once reconstituted, gentle swirling—never vigorous vortexing—should be employed to dissolve the lyophilized cake. Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and maintained at 2°C to 8°C for short-term experimentation or -80°C for extended storage. Detailed storage parameters are cataloged in our growth hormone secretagogues documentation.
Complete Evaluation Checklist for Sourcing CJC-1295 DAC
Before finalizing a purchase order for CJC-1295 DAC or any research peptide, run through this verification checklist to ensure institutional standards are met:
1. Synthesis Location: Is the peptide synthesized in a domestic, GMP-compliant facility? 2. Lot-Specific COA: Does the supplier provide third-party HPLC and MS data for the specific lot number offered? 3. Purity Rating: Is the chemical purity verified at or above 98.0%? 4. Endotoxin Screening: Has the lot passed quantitative LAL assay testing with documented EU/mg thresholds? 5. Packaging & Logistics: Is the compound shipped in lyophilized form from domestic warehouses with same-day handling? 6. Guarantees: Does the vendor offer a formal replacement or refund policy for non-conforming lots?
Frequently Asked Questions
What is the primary mechanism of CJC-1295 DAC in research models?
CJC-1295 DAC acts as a synthetic growth hormone-releasing hormone (GHRH) analog. The Drug Affinity Complex (DAC) allows covalent binding to endogenous albumin in preclinical models, extending its biological half-life and sustaining growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels for tissue repair research.
How does CJC-1295 DAC differ from CJC-1295 No DAC?
CJC-1295 DAC includes a maleimido-propionic acid linker that binds albumin, drastically extending its plasma half-life to several days. CJC-1295 No DAC lacks this linker, resulting in a rapid, short-acting half-life measured in minutes that produces transient GH pulses.
What analytical testing should a CJC-1295 DAC supplier provide?
Suppliers should provide a lot-specific Certificate of Analysis (COA) from an independent ISO 17025-accredited laboratory featuring High-Performance Liquid Chromatography (HPLC) for purity (≥98%) and Mass Spectrometry (MS) for structural identity verification.
Why is endotoxin testing necessary for CJC-1295 DAC research compounds?
Endotoxins (lipopolysaccharides) induce inflammatory responses in cell culture and animal models, distorting experimental outcomes. Endotoxin testing via LAL assays confirms that contamination levels are below strict preclinical thresholds.
Where does PX1 Research synthesize and ship its CJC-1295 DAC?
PX1 Research compounds are USA-synthesized in GMP-compliant facilities and shipped directly from domestic distribution centers in California and Arizona, offering same-day dispatch for orders placed Monday through Friday.
How should lyophilized CJC-1295 DAC be stored upon arrival at the laboratory?
Unopened, lyophilized vials should be stored at -20°C in a dry, dark location. Prior to reconstitution, vials should reach room temperature to avoid condensation. Reconstituted solution aliquots should be stored at 2°C to 8°C for short-term use or -80°C for long-term storage.
What is PX1 Research's policy if a lot fails laboratory specification checks?
PX1 Research guarantees peptide quality with third-party analytical verification. If a product fails to meet stated HPLC/MS purity standards or arrives damaged, PX1 provides full lot replacement or refund options per institutional terms.
Are wholesale or institutional purchasing options available for universities and labs?
Yes, PX1 Research provides dedicated institutional accounts, lot reservation programs, and bulk volume terms for academic, biotech, and commercial research laboratories.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.